News

The ASCO Post

By Caroline Helwick
December 15, 2013, Volume 4, Issue 20

According to an analysis of the Women’s Health Initiative, continuous combined use of estrogen plus progestin reduces the risk of endometrial cancer among postmenopausal women. The study was reported at the 2013 European Cancer Congress byRowan T. Chlebowski, MD, PhD, Professor and Chief of Medical Oncology/Hematology at the David Geffen School of Medicine at UCLA and Harbor-UCLA Medical Center, Los Angeles.1

Important Findings

LOS ANGELES – (Dec. 5, 2013) – In a finding that could expand the use of one of the most effective forms of birth control, two intrauterine contraceptive systems that had lower doses of the contraceptive hormone, levonorgestrel, were found to be safe and effective in preventing pregnancies, according to an international study that included researchers at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed).

The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) will honor one of the Palos Verdes Estate’s leading businessmen and philanthropists, Ralph Scriba, with its Award for Community Service, and one of its most distinguished researchers, Kouichi R. “Corky” Tanaka, MD, of Rancho Palos Verdes, with its Award for Inspirational Leadership at the institute’s Translating Science and Transforming Lives Gala Dec. 5 at the Beverly Wilshire Hotel in Beverly Hills.

A new study found that men who live the longest are those who have medium testosterone levels. High or low testosterone levels are linked to reduced mortality. Testosterone is a key male sex hormone involved in maintaining sex drive, sperm production and bone health. Physicians have long known that low testosterone levels can signal health problems, but the new study found men may not fare better when levels of the hormone rise too high.

American Lung Association report reveals that women are at greater risk than men

W omen are 37 percent more likely to have chronic obstructive pulmonary disease (COPD) than men and now account for more than half of all deaths attributed to COPD in our nation. The American Lung Association’s latest health disparity report, “Taking Her Breath Away: The Rise of COPD in Women,” examines the nation’s third leading cause of death and its increased prevalence among women throughout the U.S.

At one point in our lives we have all heard genes play a large part in our destiny. Yet we have seen or heard of identical twins who have gone to live extremely different lives. It is quite evident that our genes aren’t everything. Indeed the unprecedentedly increasing rates of obesity and diabetes in Australia clearly demonstrate that our choices in diet and sedentary lifestyles are impacting our health.

Medical Daily

By Peter Sergo | Oct 24, 2013 07:23 PM EDT

In 1945, Alexander Fleming, the discoverer of penicillin, already noticed bacteria’s ominous ability to acquire resistance to the antibiotic that saved so many lives. At the time, he even warned that overuse of penicillin would lead to more people dying from infections that are impervious to the revolutionary treatment.

$6.4 Million Grant Funds Study Glaucoma in African-Americans

A study led by Robert N. Weinreb, chairman and Distinguished Professor of Ophthalmology at the University of California, San Diego School of Medicine, has received a $6.4 million, 5-year grant from the National Eye Institute, part of the National Institutes of Health, to elucidate the genetics of glaucoma in persons of African descent.

By Sandy Mazza, Daily Breeze

Posted: 10/12/13, 2:55 PM PDT | Updated: on 10/14/2013

Lisa Lancaster drove an old car and wore modest clothes to the Inglewood office where she spent two decades administering nutritional and health aid to low-income women and children.

4-traders

10/03/2013 | 08:31am US/Eastern